Marine Omega-3 Supplements Tied to Higher Atrial Fibrillation Risk
Risk appeared to be greater in trials testing >1 g/day dosing
Atrial Fibrillation
Individual A-Fib Episodes Tied to Recent Alcohol Intake
AF episodes also linked to higher odds of peak blood alcohol concentration, total area under curve of alcohol exposure
Working Night Shift May Up Risk for Atrial Fibrillation
Risk increased for both current and long-term exposure to night shift work regardless of genetic risk for atrial fibrillation
Content of Omega-3 Fatty Acids in Adipose Tissue Tied to AF Risk
docosahexaenoic acid affected the risk for incident atrial fibrillation.
Rates of Adverse Events Lower With Apixaban for A-Fib in Older Adults
Apixaban the only direct oral anticoagulant linked to lower adverse event rates than warfarin for patients with atrial fibrillation across frailty levels
Catheter Ablation Improves A-Fib Outcomes in Racial/Ethnic Minorities
In contrast, much higher event rate seen for racial and ethnic minorities randomly assigned to drug therapy in CABANA trial
Risk for Atrial Fibrillation Higher Among Those With Cancer
Atrial Fibrillation risk was examined for patients with cancer from 2009 through 2017.
Finerenone Reduces New-Onset AF in Patients With CKD and T2D
Because finerenone inhibits cardiac remodeling in preclinical models, investigators sought to examine its effect on new-onset AFF by analyzing data from the FIDELIO-DKD phase 3 trial.
Kidney Impairment Influences Safety, Efficacy of Anticoagulants for AFib
Investigators found an incremental increase in risks from oral anticoagulants as kidney function decreased, highlighting the need for more research to better understand bleeding risk and net benefit of treatment in the CKD population.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...